Philips Introduces Cutting-Edge 3D Heart Imaging Technology
Philips Unveils Advanced 3D Heart Imaging Catheter
Philips has launched its groundbreaking VeriSight Pro 3D Intracardiac Echocardiography (ICE) catheter across Europe, marking a significant milestone in the realm of minimally invasive heart procedures. This state-of-the-art technology allows for real-time 3D imaging directly within the heart chambers, transforming how cardiovascular interventions are performed.
Pioneering Technology for Enhanced Patient Safety
The VeriSight Pro catheter is a miniaturized ultrasound device that is embedded at the tip of a thin, steerable catheter. This innovation enables healthcare professionals to visualize critical cardiac anatomy in real time during procedures such as transcatheter valve repair or left atrial appendage closure. By eliminating the need for general anesthesia, the catheter not only enhances patient comfort but also streamlines the entire treatment process.
Transforming Clinical Workflows
With the ability to provide high-resolution 2D and 3D images of the heart, the VeriSight Pro helps support confident clinical decision-making while minimizing procedure time and optimizing resources. As mentioned by Prof. Dr. Jörg Hausleiter from Ludwig-Maximilians-Universität in Munich, this technology greatly improves protocol efficiency and the accessibility of complex procedures for patients who might struggle with more invasive imaging methods.
Addressing Growing Needs in Cardiac Care
As structural heart disease continues to pose a rising challenge in healthcare, the introduction of the VeriSight Pro comes at a crucial time. Many cardiac interventions today rely on transesophageal echocardiography (TEE), which often involves general anesthesia and longer hospital stays. The new catheter aims to alleviate these challenges by offering detailed imaging with a simple femoral vein entry, thus reducing the overall burden on patients and healthcare facilities.
Innovative Features of VeriSight Pro
The unique design of the VeriSight Pro includes advanced features such as xPlane and iRotate technologies, allowing clinicians to visualize multiple imaging planes simultaneously and adjust views digitally. This user-friendly approach enhances procedural accuracy and can significantly lower the number of imaging steps required during interventions.
Philips' Commitment to Integrated Healthcare Solutions
As part of a robust ecosystem for structural heart disease management, the VeriSight Pro seamlessly integrates with Philips’ EPIQ ultrasound systems and the Azurion image-guided therapy platform. This integration supports a comprehensive solution for clinicians working on various heart conditions, including tricuspid and mitral valve repairs and left atrial appendage occlusion.
Showcasing Innovations at EuroPCR 2025
Philips plans to showcase the capabilities of the VeriSight Pro during EuroPCR 2025 in Paris, featuring live demonstrations and training sessions led by expert clinicians. These events will provide valuable insights into the practical applications of 3D ICE in real-world settings, including its impact on clinical outcomes and workflow integration.
About Royal Philips
Founded with a vision to enhance health and well-being through meaningful innovations, Royal Philips (NYSE: PHG, AEX: PHIA) focuses on delivering advanced healthcare solutions. With a workforce of approximately 67,200 people operating in over 100 countries, Philips generated substantial sales in the previous year and continues to push the boundaries of medical technology.
For more information, please reach out to:
Joost Maltha
Philips Global External Relations
Tel.: +31 6 10 55 8116
E-Mail: joost.maltha@philips.com
Frequently Asked Questions
What is the VeriSight Pro 3D ICE catheter?
The VeriSight Pro 3D ICE catheter is an innovative device that provides real-time 2D and 3D imaging inside the heart, enhancing minimally invasive procedures.
How does this technology improve patient care?
This catheter eliminates the need for general anesthesia, which improves patient comfort and reduces recovery time, leading to shorter hospital stays.
What types of procedures can utilize the VeriSight Pro?
The catheter is designed for procedures such as transcatheter valve repair and left atrial appendage closure.
How does the VeriSight Pro enhance clinical workflows?
It offers precise imaging capabilities, allowing physicians to make confident clinical decisions and streamline procedural processes.
Where can clinicians learn more about the VeriSight Pro's application?
Clinicians can learn more at EuroPCR 2025, where Philips will host demonstrations and training sessions focused on this technology.
About The Author
Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
